Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041331 | SCV000065024 | benign | not specified | 2015-09-29 | criteria provided, single submitter | clinical testing | p.Leu587Leu in exon 11 of LMNA: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.7% (36/5272) of Finnish chromosomes and 0.3% (187/59480) of European chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org/; dbSNP rs80356813). |
Eurofins Ntd Llc |
RCV000041331 | SCV000114726 | likely benign | not specified | 2015-10-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001085192 | SCV000291553 | benign | Charcot-Marie-Tooth disease type 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041331 | SCV000316407 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000249377 | SCV000318704 | likely benign | Cardiovascular phenotype | 2015-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV000041331 | SCV000595613 | likely benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710161 | SCV000614026 | benign | not provided | 2017-10-19 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000030149 | SCV000901154 | benign | Cardiomyopathy | 2016-02-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000030149 | SCV000910777 | benign | Cardiomyopathy | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172632 | SCV001335695 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000710161 | SCV001746873 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | LMNA: BP4, BS2 |
Gene |
RCV000710161 | SCV001941598 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996128 | SCV004831189 | benign | Primary dilated cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030149 | SCV000052804 | benign | Cardiomyopathy | 2015-05-20 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000041331 | SCV001744437 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041331 | SCV001917059 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041331 | SCV001930647 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041331 | SCV001959722 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000710161 | SCV001975391 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000041331 | SCV002035596 | benign | not specified | no assertion criteria provided | clinical testing |